Skip to main content

Unicycive Therapeutics, Inc.

UNCY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001766140

No open-market purchases or sales by Unicycive Therapeutics, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $54.6M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Unicycive Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
51
+17 vs. Q4 2025
Shares held
9.91M
+2.46M (+33.0%) vs. Q4 2025
Total value
$65.2M
+$22.2M (+51.7%) vs. Q4 2025
New holders
20
10 more added
Sold out
3
11 more reduced

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting UNCY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 51 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 10 institutionsQ4 2021: 12 institutionsQ1 2022: 12 institutionsQ2 2022: 15 institutionsQ3 2022: 12 institutionsQ4 2022: 9 institutionsQ1 2023: 13 institutionsQ2 2023: 15 institutionsQ3 2023: 16 institutionsQ4 2023: 16 institutionsQ1 2024: 23 institutionsQ2 2024: 24 institutionsQ3 2024: 29 institutionsQ4 2024: 31 institutionsQ1 2025: 29 institutionsQ2 2025: 20 institutionsQ3 2025: 30 institutionsQ4 2025: 35 institutionsQ1 2026: 51 institutionsQ2 2026: 79 institutions
Value heldQ1 2026: $65.2M
Q1 2021: $0Q2 2021: $0Q3 2021: $3.02MQ4 2021: $2.30MQ1 2022: $1.48MQ2 2022: $992.0KQ3 2022: $571.0KQ4 2022: $428.3KQ1 2023: $3.54MQ2 2023: $1.38MQ3 2023: $12.2MQ4 2023: $11.3MQ1 2024: $31.6MQ2 2024: $9.52MQ3 2024: $19.1MQ4 2024: $49.0MQ1 2025: $34.5MQ2 2025: $24.6MQ3 2025: $27.4MQ4 2025: $47.5MQ1 2026: $65.2MQ2 2026: $54.6M
Institutions holding UNCY and their total value by quarter
QuarterHoldersValue
Q2 202679$54.6M
Q1 202651$65.2M
Q4 202535$47.5M
Q3 202530$27.4M
Q2 202520$24.6M
Q1 202529$34.5M
Q4 202431$49.0M
Q3 202429$19.1M
Q2 202424$9.52M
Q1 202423$31.6M
Q4 202316$11.3M
Q3 202316$12.2M
Q2 202315$1.38M
Q1 202313$3.54M
Q4 20229$428.3K
Q3 202212$571.0K
Q2 202215$992.0K
Q1 202212$1.48M
Q4 202112$2.30M
Q3 202110$3.02M
Q2 20210$0
Q1 20210$0

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Unicycive Therapeutics, Inc.; share changes are against Q4 2025.

Institutions holding UNCY in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Citigroup Inc1$70.00%−227−99.6%Reduced
Danske Bank A/S1$70.00%00.0%Unchanged
Caitong International Asset Management Co., Ltd5$330.00%+5New
Bogart Wealth, LLC6$390.00%00.0%Unchanged
Fortitude Family Office, LLC75$4940.00%+75New
Harbour Investments, Inc.100$6580.00%00.0%Unchanged
TFC Financial Management300$1.97K0.00%00.0%Unchanged
Royal Bank of Canada377$2.00K0.00%+377New
SBI Securities Co., Ltd.557$3.67K0.00%−1−0.2%Reduced
Rockefeller Capital Management L.P.1,600$10.5K0.00%+1,100+220.0%Added
Simplex Trading, LLC5,820$38.3K0.00%+5,820New
Vanguard Global Advisers, LLC7,867$51.8K0.00%+7,867New
Prelude Capital Management, LLC12,231$80.5K0.01%+12,231New
UBS Group AG19,444$127.9K0.00%−461−2.3%Reduced
XTX Topco Ltd22,604$148.7K0.00%−12,801−36.2%Reduced
Renaissance Technologies LLC24,400$160.6K0.00%+24,400New
Chicago Partners Investment Group LLC21,778$167.9K0.00%−635−2.8%Reduced
Virtu Financial LLC26,274$173.0K0.01%+26,274New
Persistent Asset Partners Ltd26,827$176.5K0.07%+26,827New
Goldman Sachs Group Inc27,093$178.3K0.00%+27,093New
Quadrature Capital Ltd27,917$183.7K0.00%−11,197−28.6%Reduced
Bank of America Corp29,530$194.3K0.00%+29,378+19,327.6%Added
Omers Administration Corp31,900$209.9K0.00%−46,300−59.2%Reduced
BlackRock, Inc.35,903$236.2K0.00%−452−1.2%Reduced
Northern Trust Corp35,937$236.5K0.00%00.0%Unchanged
HRT Financial LP41,492$273.0K0.00%+41,492New
Barclays PLC50,000$329.0K0.00%+49,920+62,400.0%Added
Seven Fleet Capital Management LP55,700$366.5K0.12%+55,700New
Acuta Capital Partners, LLC57,959$381.4K0.27%−2,026−3.4%Reduced
Jane Street Group, LLC72,243$475.4K0.00%+72,243New
Cantor Fitzgerald, L. P.75,000$493.5K0.02%−125,000−62.5%Reduced
State Street Corp80,027$526.6K0.00%+14,800+22.7%Added
Diametric Capital, LP80,362$528.8K0.14%+80,362New
Vanguard Fiduciary Trust Co101,074$665.1K0.00%+101,074New
Diadema Partners LP106,083$698.0K0.29%+106,083New
BNP Paribas Arbitrage, SA119,531$786.5K0.00%+19,789+19.8%Added
Dimensional Fund Advisors LP143,052$940.2K0.00%+143,052New
Dauntless Investment Group, LLC147,087$967.8K2.72%+57,672+64.5%Added
Marshall Wace, LLP154,938$1.02M0.00%+154,938New
Morgan Stanley188,182$1.24M0.00%+141,598+304.0%Added
Susquehanna International Group, LLP199,219$1.31M0.00%+174,288+699.1%Added
Geode Capital Management, LLC203,744$1.34M0.00%+32,454+18.9%Added
Integral Health Asset Management, LLC225,000$1.48M0.08%+225,000New
Citadel Advisors LLC236,841$1.56M0.00%−21,460−8.3%Reduced
Logos Global Management LP473,563$3.12M0.16%00.0%Unchanged
Great Point Partners LLC796,558$5.24M1.28%00.0%Unchanged
Vanguard Capital Management LLC811,430$5.34M0.00%+811,430New
Nantahala Capital Management, LLC939,202$6.18M0.39%00.0%Unchanged
Octagon Capital Advisors LP1,000,000$6.58M0.73%00.0%Unchanged
Millennium Management LLC1,399,348$9.21M0.01%+384,505+37.9%Added
Vivo Capital, LLC1,789,916$11.8M0.98%00.0%Unchanged
Pavaki Capital Management LLC0$00.00%−90,000−100.0%Sold out
Squarepoint Ops LLC0$00.00%−55,305−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−1,920−100.0%Sold out
Vanguard Group Inc––––Not filed